Clinical Trial Results:
An open-label, single arm, phase II trial to investigate the safety and efficacy of Sym004 in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) who have failed anti-EGFR monoclonal antibody-based therapy
Summary
|
|
EudraCT number |
2011-000902-24 |
Trial protocol |
BE DE |
Global completion date |
08 Oct 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
04 Sep 2016
|
First version publication date |
04 Sep 2016
|
Other versions |
|
Summary report(s) |
Final Synopsis Clinical Trial Results for Sym004-02 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.